Oncoinvent ASA

Oncoinvent ASA is a clinical-stage company that develops radiopharmaceutical therapies for cancer. Its lead product candidate, Radspherin, is an alpha-radiation therapy candidate for treating cancer that has spread to body cavities, including the peritoneum, and is being evaluated in two phase 1/2a trials and one randomized phase 2 trial. The company is based in Oslo, Norway.